Although many endovascular treatment options exist, nitinol stents remain a mainstay of SFA therapy. 1 This article reviews the historical development of SFA stent technologies, with an emphasis on recent advances and data supporting the use of …

Percutaneous transluminal angioplasty of superficial femoral artery is a proven, viable, safer, and effective option, with good mid-term clinical results and patency rates. Different approaches to be chosen depends on the anatomical and technical factors to get the best possible outcome.

Due to some dissection and recoil, especially near the ostium of the SFA, I placed a 6- X 150-mm Supera nitinol woven stent (Abbott Vascular) via retrograde SFA access from the ostium of the SFA to the mid artery.

2013年12月4日 · I typically treat small arteries (<5mm diameter) and lesions under 3–5cm with angioplasty alone with stent placement only for dissection or failed angioplasty (recoil). I will treat lesions 3–10cm with bare metal self-expanding stent placement. I favour the LifeStent, Complete or Absolute stent.

Although many endovascular treatment options exist, nitinol stents remain a mainstay of SFA therapy.1 This article reviews the historical devel-opment of SFA stent technologies, with an emphasis on recent advances and data supporting the use of …

Diagnostic iliac, femoral, and popliteal angiograms are performed to assess the extent and burden of disease. Given that the disease is limited to the mid to distal femoral artery, a decision is made to undergo balloon angioplasty and subsequent stent insertion with a Viabond stent graft.

The superficial femoral artery (SFA) poses unique challenges for endovascular stenting. It is a long, muscular artery that is fixed between the hip and the knee; as a result of the complex motions of the hip joint, the SFA is subject to unique forces, including flexion, extension, and …

2016年1月19日 · Drug-eluting stents (DES) are the default strategy for superficial femoral artery (SFA) intervention in 2015 because they have been evaluated in a large number of patients over a long follow-up period with outcomes superior to other treatment options. No other therapy can make that claim.

2004年6月21日 · This report outlines the unique and extensive experience of a combined surgery and interventional radiology program at the University of Rochester with percutaneous transluminal angioplasty and stenting for symptomatic atherosclerotic SFA occlusive disease using an aggressive treatment strategy.

Early studies of sirolimus- and everolimus-eluting self-expanding nitinol stent platforms for the superficial femoral artery (SFA) dem-onstrated early efficacy followed by disappointing longer-term results.